HSBC Holdings’s Gossamer Bio GOSS Stock Holding History

HSBC Holdings’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.8K	Buy	+113,943	New	+$179K	﹤0.01%	2825
2025 Q4	–	Sell	-25,969	Closed	-$68.2K	–	3023
2025 Q3	$68.2K	Buy	25,969 +7,903	+44%	+$17.4K	﹤0.01%	2625
2025 Q2	$23K	Buy	+18,066	New	+$19.7K	﹤0.01%	2973
2021 Q1	–	Sell	-12,037	Closed	-$117K	–	2887
2020 Q4	$117K	Buy	+12,037	New	+$119K	﹤0.01%	2930
2020 Q3	–	Sell	-10,498	Closed	-$136K	–	2782
2020 Q2	$136K	Buy	+10,498	New	+$132K	﹤0.01%	2469
2019 Q4	–	Sell	-21,243	Closed	-$357K	–	3097
2019 Q3	$357K	Buy	+21,243	New	+$422K	﹤0.01%	2519

Other funds holding GOSS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

HSBC Holdings's GOSS Position: Q1 2026 in Review

HSBC Holdings opened a new position in Gossamer Bio (GOSS) in Q1 2026: 113,943 shares worth $37.8K. The stake represents ﹤0.01% of the portfolio and ranks #2825 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in GOSS as recently as Q3 2025.

HSBC Holdings first reported a position in GOSS in Q3 2019 and has held it in 6 quarters since. The position peaked at $357K in Q3 2019. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

HSBC Holdings held 113,943 shares of Gossamer Bio worth $37.8K as of Q1 2026.
Gossamer Bio was a new HSBC Holdings position in Q1 2026.
Gossamer Bio made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2825 holding.
HSBC Holdings first reported a position in Gossamer Bio in Q3 2019 and has held it in 6 quarters since.
HSBC Holdings's Gossamer Bio position peaked at $357K in Q3 2019.
184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.